Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study.
about
Fungal allergy in asthma-state of the art and research needsMicrobiome and Asthma: What Have Experimental Models Already Taught Us?'The Microbiome and the Pathophysiology of Asthma'Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during ExacerbationBlocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthmaThe relationships between environmental bacterial exposure, airway bacterial colonization, and asthma2-hydroxyisocaproic acid is fungicidal for Candida and Aspergillus species.Asthma microbiome studies and the potential for new therapeutic strategiesThe lung mycobiome: an emerging field of the human respiratory microbiome.The mycobiota: interactions between commensal fungi and the host immune system.Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal.Microbiome diversity and asthma and allergy risk.The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus-related lung disease.A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS).Mycobiome in the Lower Respiratory Tract - A Clinical Perspective.The microbiome and asthma.Microbiome effects on immunity, health and disease in the lung.Ionic Liquids as Unforeseen Assets to Fight Life-Threatening Mycotic Diseases.Role of Microbial Modulation in Management of Atopic Dermatitis in Children.Forgotten fungi-the gut mycobiome in human health and disease.The microbiome in allergic disease: Current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology.The microbiome in asthma.The lung mycobiome in the next-generation sequencing era.Identification of fungal candidates for asthma protection in a large population-based study.Fungal dysbiosis: immunity and interactions at mucosal barriers.The nutrition-gut microbiome-physiology axis and allergic diseases.High diversity of non-sporulating moulds in respiratory specimens of immunocompromised patients: should all the species be reported when diagnosing invasive aspergillosis?The microbiome of the human lower airways: a next generation sequencing perspective.Aging and the microbiome: implications for asthma in the elderly?Immune development and environment: lessons from Amish and Hutterite children.Spondyloarthritis, Acute Anterior Uveitis, and Fungi: Updating the Catterall-King Hypothesis.Commensal Fungi in Health and Disease.Characterizing the Human Mycobiota: A Comparison of Small Subunit rRNA, ITS1, ITS2, and Large Subunit rRNA Genomic TargetsInnate and adaptive immune responses to fungi in the airway
P2860
Q22001138-F864FFDD-DAD8-4ECF-A110-A5E80E23E64BQ26798677-68FA0B9B-1A71-4F86-8ADB-9A677566F6E5Q28077213-899BA4EB-8FCE-426B-B7C4-283F5BE2F4B1Q28584597-2698E750-8B8C-4A3A-B17D-0AF1BCBC8472Q33556185-AF1A2BE8-86E0-4750-8FD9-DF06D1B9601EQ33999431-2048FAA0-3343-4893-8F23-C27F71EC401AQ34377635-8AE5816A-3C6A-41E6-A3B8-93582CF7F555Q34741123-979AF9A1-20AB-450C-96B5-F2539B64A3DBQ35082308-CD080FAB-82F7-4DF0-BF28-C7639A4220F4Q35096262-03220601-10F9-476D-82CB-1B20348E64E1Q35116209-75FAEE12-9E44-42B2-A684-58132B6773ADQ35230090-16BB1ED4-E9A4-4F11-A0CD-237C85A1E315Q35277785-7BC88614-1142-40DB-A83E-2FD3888C2418Q35824636-A0B9BC7B-1124-4BBB-B607-497FA6D5306FQ37574834-ABA9F0EC-54F6-4890-8DB5-70C4CFD7CF2EQ37679762-FFDD2A8C-AC37-4191-A90D-4C5DC7FD4E75Q37739364-DC2219FB-07CD-4C46-AEFB-B73D184938B3Q38279678-8DD72E94-65A9-4C86-BF2F-A2C3E73C4697Q38632479-C77CF052-420C-492C-823F-AE56A203001FQ38692272-2D4EFFA0-75AF-4C5B-B847-32F9E7513AABQ38750982-12F72B7A-8137-4B17-9D4C-28295EA85ABEQ38949256-9D2D726F-C378-4AAE-BB80-FA6C54D393FAQ38968543-FD695298-E9FE-4AC9-9FFE-EBD1A5627349Q39278473-D1A2AF0F-E003-4BF2-AB9F-2BEBAB76623EQ39366659-305D0735-7E55-4168-A736-3711EEC337FBQ39402852-7D28A2A3-03C3-47D6-A0DB-F2957664413DQ41088481-A2635980-4EF2-4B4A-AFD1-17F88F130DD7Q46093186-8236E338-C280-4DDE-97C2-272E04C4A14AQ46787507-B9D0106A-A1B2-4290-A893-CCD6983B367AQ47287611-9EF8D1F2-CD1A-47C3-93E9-80F14CA80E33Q52575771-010C7B92-9499-4A52-B292-9238360C2B55Q52759357-D8B12F38-D0B7-424C-A285-729B079A968FQ57072800-34A495BC-9DF3-4B07-952C-9C21BF77A236Q57172513-1DD742D4-F5A4-4A9D-849A-3FE0B13C6B36
P2860
Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Differences in fungi present i ...... nity based case control study.
@ast
Differences in fungi present i ...... nity based case control study.
@en
Differences in fungi present i ...... nity based case control study.
@nl
type
label
Differences in fungi present i ...... nity based case control study.
@ast
Differences in fungi present i ...... nity based case control study.
@en
Differences in fungi present i ...... nity based case control study.
@nl
prefLabel
Differences in fungi present i ...... nity based case control study.
@ast
Differences in fungi present i ...... nity based case control study.
@en
Differences in fungi present i ...... nity based case control study.
@nl
P2860
P50
P356
P1476
Differences in fungi present i ...... unity based case control study
@en
P2093
Ian Price Matthews
Richard Brown
P2860
P2888
P356
10.1186/1471-2334-13-69
P577
2013-02-05T00:00:00Z
P5875
P6179
1004238219